John M. Maris
John Matthew Maris kwararre ne a fannin ilimin likitan yara na Amurka. Shi ne Farfesa Giulio D'Angio Endowed Farfesa na Pediatrics a Asibitin Yara na Philadelphia (CHOP) da kuma cikakken Farfesa a makarantar medicine na parelman a jami'ar pennnsylvania.

Rayuwar farko da ilimi 
Maris ya kammala digirinsa na farrko na kimiyya daga Jami'ar Wheeling a 1983 da digirinsa na likitanci daga Makarantar Magunguna ta Perelman a Jami'ar Pennsylvania a 1989.

Sana'a 
Bayan kammala karatunsa na yau da kullun, an nada Maris a matsayin mataimakin farfesa a fannin ilimin yara a Makarantar Magunguna ta Perelman a Jami'ar Pennsylvania a 1996.  Yayin aiki a cikin wannan rawar, Maris da ƙungiyar bincikensa sun mayar da hankali kan ciwon daji na yara neuroblastoma da fahimtar cututtukan ƙwayoyin cuta zuwa ingantattun ƙimar rayuwa. Sun yi amfani da dabarun haɗin kai, haɗa nau'ikan kwayoyin halitta da dabarun aiki don ba da fifiko ga maƙasudin ƙwayoyin cuta don cimma cikakkiyar tsarin kula da neuroblastoma.  Daga karshe an kara masa girma zuwa matsayin mataimakin farfesa kuma aka zabe shi ga kungiyar bincike kan yara .  Bayan haka, an kuma zaɓe shi ga Ƙungiyar Binciken Kiwon Lafiya ta Amirka a 2007. 

A cikin 2008, Maris ya jagoranci ƙungiyar da ta gano bambance-bambancen DNA na kowa akan chromosome 6, karo na farko da masu bincike suka gano asalin halittarsa.  Ya kuma yi aiki tare da likitan-masanin kimiyya Yael Moss don gwada maganin crizotinib a matsayin yiwuwar maganin neuroblastoma.  A shekara ta 2010, Maris an nada shi shugabar Oncology a Asibitin Yara na Philadelphia da kuma darektan Cibiyar Nazarin Ciwon Kankara ta Asibiti.  A cikin 2013, Maris da likita Crystal Mackall an nada su a matsayin masu haɗin gwiwa na Stand Up to Cancer -St. Baldrick's Foundation Immunogenomics Dream Team. Ƙungiyar binciken za ta yi amfani da kwayoyin halitta don gano maƙasudin maganin CAR T-cell.  A cikin Janairu 2013, Maris tare da haɗin gwiwar Haɗuwar Farfaɗo Targeting da Chk1 da Wee1 Kinases yana Nuna Ƙarfin Lafiya a cikin Neuroblastoma wanda shine haɗin gwiwar jami'an bincike ya rage girman ci gaban neuroblastomas a cikin mice.  Daga baya waccan shekarar, ya gwada maganin binciken LEE011 akan rage jinkirin ci gaban neuroblastomas a cikin mice.  Kungiyar Mafarki daga baya ta gano takamaiman takamaiman hari a cikin babban haɗari neuroblastoma kuma sun ƙirƙira tsarin salon salula wanda aka yiwa waɗannan makasudi tare da yin kisa mai ƙarfi akan ƙwayoyin ƙari. 

A yayin bala'in COVID-19, Ƙungiyar Mafarki ta Maris ta sami lambar yabo ta 2021 American Association for Cancer Research Team Science Award.

Manazarta